Tagged: nanotechnology

Prien and MacWilliam bequests establish new endowed professorships

The UCSF School of Pharmacy has established new endowed faculty positions to be held by the chairs of two School departments.

Major funding for The Kidney Project from NIBIB Quantum Program

The research journey toward building a fully functioning, surgically implantable artificial kidney as an alternative to kidney transplant and dialysis just took another step forward with the announcement of a $6 million grant to The Kidney Project, headquartered at the UCSF School of Pharmacy. The funding comes from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), one of the National Institutes of Health (NIH).

Desai elected to the National Academy of Medicine

UCSF School of Pharmacy faculty member Tejal Desai, PhD, has been newly elected to the National Academy of Medicine (NAM), formerly known as the Institute of Medicine (IOM).

NAM membership is considered one of the highest honors in health and medicine. Elected by current members, the membership recognizes individuals who have made major contributions to the advancement of the medical sciences, health care, and public health.

Desai lab develops nano-devices to aid artery repair

Research in the laboratory of Tejal Desai, PhD, is creating new kinds of drug delivery devices to reduce the scarring and inflammation that can undermine stents—metal mesh tubes implanted to prop open blocked arteries, including in the heart.

Tejal Desai, PhD

Professor & Chair

I am a bioengineer focusing on micro and nanofabrication techniques to create new devices for drug and cell delivery as well as biomaterials for cell and tissue regeneration. I also chair the Department of Bioengineering and Therapeutic Sciences.

Shuvo Roy, PhD

Professor

I am a bioengineer working on medical device development to address clinical needs by leveraging my background in MEMS (microelectromechanical systems) along with advances in biomaterials, electronics, and nanotechnology to advance health world-wide.

New NIH funding awarded to the Department of Bioengineering and Therapeutic Sciences in 2011

New research support awarded to the UCSF School of Pharmacy by the National Institutes of Health during the 2011 fiscal year included a half-dozen on-going projects by BTS faculty:

In-flight programming features bioartificial kidney

 Passengers who travel on American Airlines from September through October 2011 will learn about the surgically implantable bioartificial kidney being developed at UCSF as a permanent solution to end stage renal disease.

SmartPlanet video features The Kidney Project

The implantable bioartifical kidney is explained in this December 6, 2010, SmartPlanet video featuring Shuvo Roy, PhD, a faculty member in the UCSF Schools of Pharmacy and Medicine.

Shuvo Roy shares promise of bioartifical kidney

Shuvo Roy, PhD, an engineer and research scientist, is leading a U.S. project to build the world’s first bioartifical kidney to treat end stage renal disease. The goal is to surgically implant this coffee-cup-sized device in a human patient within 5 to 7 years. The bioartificial kidney both filters toxins from the blood and performs many of the metabolic functions of the healthy kidney. And, the bioartificial kidney requires no batteries or external pumps.

Pages